Thorne Healthtech Intrinsic Value Calculator – THORNE HEALTHTECH Reports Record-Breaking Q2 Revenue Growth of 29.7%

August 11, 2023

☀️Earnings Overview

On August 8 2023, THORNE HEALTHTECH ($NASDAQ:THRN) announced results for the second quarter of FY2023 (ending June 30 2023), with total revenue reaching USD 72.7 million, a considerable increase of 29.7% compared to the same period in the previous year. Furthermore, their net income increased by 179.6% to USD 4.4 million.

Analysis – Thorne Healthtech Intrinsic Value Calculator

GoodWhale has conducted an analysis of THORNE HEALTHTECH‘s financials and determined the fair value of THORNE HEALTHTECH share to be around $6.2. This calculation was done using our proprietary Valuation Line. Despite this fair value, the current market value of THORNE HEALTHTECH stock is being traded at $5.8, which is undervalued by 6.7%. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Thorne Healthtech. More…

    Total Revenues Net Income Net Margin
    255.95 20.33 7.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Thorne Healthtech. More…

    Operations Investing Financing
    21.52 -40.59 18.55
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Thorne Healthtech. More…

    Total Assets Total Liabilities Book Value Per Share
    282.53 127.27 2.86
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Thorne Healthtech are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    30.7% 6.0%
    FCF Margin ROE ROA
    -5.9% 6.4% 3.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    The health technology industry is a highly competitive market. Thorne has a strong track record of innovation and success, which has allowed it to maintain its position as a top player in the health technology industry.

    – Vitana-X Inc ($OTCPK:VITX)

    Vitana-X Inc is a company that specializes in the development and sale of vitamins and supplements. The company has a market cap of 413.71k as of 2022 and a return on equity of 270.71%. Vitana-X Inc has been in business for over 20 years and is a well-established company in the industry. The company’s products are available in over 50 countries and are sold through a variety of channels, including online, retail, and wholesale. Vitana-X Inc is a publicly traded company on the OTCQB exchange under the ticker symbol VTXI.

    – By-health Co Ltd ($SZSE:300146)

    The company’s market cap is 30.57B as of 2022. The company’s ROE is 11.34%. The company is involved in the manufacture and sale of health products.

    – Wellnex Life Ltd ($ASX:WNX)

    Wellnex Life Ltd is a biotechnology company that focuses on the development and commercialization of products for the treatment of osteoporosis and other bone-related diseases. The company has a market cap of 25.9M as of 2022 and a Return on Equity of -62.84%. Wellnex Life Ltd is headquartered in Vancouver, Canada.


    Investors are likely to have mixed views of THORNE HEALTHTECH after their latest earnings report. Although the company reported a 29.7% increase in total revenue, from USD 72.7 million to USD 4.4 million, and a 179.6% increase in net income, the stock price declined the same day. This suggests that investors are perhaps expecting more from the company, given its high growth potential and long-term outlook. Analysts may now focus on whether THORNE HEALTHTECH can sustain its impressive growth and deliver consistent returns in the future.

    Recent Posts

    Leave a Comment